Efficacy and Safety of HAIC in Combination With TQB2868 and Ramucirumab for Second-line Treatment of Advanced Hepatocellular Carcinoma
Clinical trial NCT06441019 · UNKNOWN
Trial details
- NCT number
- NCT06441019
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2025-05-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.